Valero Energy Corporation (VLOE34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 130.00 |
|---|---|
| 52-week range | 54.73 – 146.90 |
| Return, 1 month / 3 months | +1.6% / +37.3% |
| Return, 1 year / 3 years | +167.8% / +437.3% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 45.6% |
| Worst drawdown (1 year) | -17.0% |
| Average daily value traded | 0.09M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Valero Energy Corporation is a petroleum refining and marketing company based in San Antonio, Texas. It operates refineries that turn crude oil into gasoline, diesel, jet fuel and other refined products, which it sells through wholesale and retail channels under brands such as Valero and Diamond Shamrock. The company also produces ethanol and renewable diesel, and its customers include fuel distributors, retailers and industrial users across the United States and other markets.
Valero Energy Corporation is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code VLOE34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Valero Energy Corporation (VLOE34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 130.00 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 57 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 167.8% and over the last three months it rose 37.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 46.5% | ||
| From 52-week high | -11.2% | ||
| Momentum | 95 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 37.3% | ||
| 6-month return | 91.3% | ||
| 12-month return, skipping the last month | 163.7% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 45.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.0% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.09M BRL | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | +1.6% |
| 3 months | +37.3% |
| 6 months | +91.3% |
| 1 year | +167.8% |
| 3 years | +437.3% |
| 5 years | +1,567.4% |
Signals
| 50-day / 200-day average | 126.79 / 88.73 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Jul 2026 | USD 16.5506 |
| 19 May 2026 | USD 16.9133 |
| 3 Feb 2026 | USD 16.7587 |
| 17 Nov 2025 | USD 16.8629 |
| 29 Jul 2025 | USD 16.6566 |
| 16 May 2025 | USD 16.8006 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.